In a breast imaging population, about 1 in 25 will be eligible for genetic testing.

If you are only using BRCAPRO, only 1 in 200 will need an MRI.  Use Tyrer Cuzick 7, and you will see that about 15% will need an MRI.

[ASCO_2014_NCCNB_BRCAPRO_TyrerCuzickRiskMutationsLifetimeRisk]

Share This